ADVFN - Advanced Financial Network.
HOME» NYSE » M » MRK Stock Price » MRK Stock News

Merck Share News

 Merck & Co., Stock Price
MRK Stock Price
 Merck & Co., Stock Chart
MRK Stock Chart
 Merck & Co., Stock News
MRK Stock News
 Merck & Co., Company Information
MRK Company Information
 Merck & Co., Stock Trades
MRK Stock Trades

MARKET SNAPSHOT: U.S. Stocks Rally, Dow Tops 13,000

By Kate Gibson, MarketWatch NEW YORK (MarketWatch) -- U.S. stocks rallied on Friday, reclaiming weekly gains and pushing the Dow Jones Industrial Average to a nearly three-month high, as investors anticipated central-bank moves in Europe as well as by the U.S. Federal Reserve. Stocks hit session highs after Bloomberg News reported European Central Bank President Mario Draghi would hold talks with Bundesbank President Jens Weidmann in an attempt to remove the biggest obstacles to adopting new measures including bond purchases. "Between Draghi's comments and the GDP numbers today, we're bid up on prospects of monetary intervention," said Mark Luschini, chief investment strategist at Janney Montgomery Scott. After a 229-point rise, the Dow Jones Industrial Average (DJI) was lately up 179.25 points, or 1.4%, to 13,065.89, its first intraday rise above 13,000 since May 8. Merck & Co. Inc. (MRK) led the gains that included all but three of its 30 components. Merck shares rallied 3.8% after the pharmaceutical company's earnings topped forecasts. The S&P 500 index (SPX) added 23.03 points, or 1.7%, to 1,383.05, with health care and industrials the best performing of its 10 major industry sectors. Amgen Inc. (AMGN) gained 4.7% after the biotechnology company raised its 2012 outlook and reported second-quarter profit that exceeded analysts' estimates. The Nasdaq Composite (RIXF) gained 55.48 points, or 1.9%, to 2,948.71. Facebook Inc. (FB) shares slid 12% after the social-networking site offered little reassurance to investors concerned about its lofty valuation. For every stock declining, five gained on the New York Stock Exchange, where 491 million shares were exchanged as of 2:30 p.m. Eastern. Global equities gained after German Chancellor Angela Merkel and French President Francois Hollande said they were committed to keeping the euro area together. French newspaper Le Monde reported the European Central Bank was readying to purchase debt. The major stock indexes held gains after a gauge of consumer sentiment came in just above expectations, as did a separate report on U.S. economic growth in the second quarter. . Subscribe to WSJ:

Stock News for Merck (MRK)
10/21/201621:57:00FDA Approves Merck’s ZINPLAVA™ (bezlotoxumab) to Reduce Recurrence of...
10/21/201606:45:00Merck’s KEYNOTE-045 Studying KEYTRUDA® (pembrolizumab) in Ad...
10/19/201607:00:00Merck Announces Pivotal Phase 3 Study of Letermovir, an Investigational...
10/17/201617:00:00Merck Research Laboratories Facilities Designated as “Milestones i...
10/14/201608:30:00Merck Launches Biosimilars Clarified, a New Online Educational...
10/10/201602:49:00Merck Announces Recipients of Third Annual €1 Million 'Grant f...
10/09/201602:44:00Study May Boost Use of Merck Lung-Cancer Drug
10/09/201602:16:00Two Major Studies to Be Presented at ESMO 2016 Congress Presidential...
10/09/201602:15:00KEYTRUDA® (pembrolizumab) Showed Continued Overall Survival...
10/08/201608:45:00Merck Announces Longer-Term Follow-Up of Overall Survival Data...
10/08/201602:15:00New KEYTRUDA® (pembrolizumab) Data in Advanced Urothelial Cancer...
10/07/201616:05:00Merck Animal Health Announces USDA Approval of Innovative Canine...
10/04/201618:03:00FDA Warns on Hepatitis C Drugs
10/04/201617:14:53Statement of Changes in Beneficial Ownership (4)
10/04/201617:14:53Statement of Changes in Beneficial Ownership (4)
10/04/201617:14:53Statement of Changes in Beneficial Ownership (4)
10/04/201617:14:26Statement of Changes in Beneficial Ownership (4)
10/04/201617:14:26Statement of Changes in Beneficial Ownership (4)
10/04/201616:10:00NewLink Genetics Awarded $25 Million Contract from BARDA for...
10/03/201623:00:00Samsung Affiliate Seeks European Approval for Herceptin Copy

Merck and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations